|
|
- ゆあ おおふさ
- 7 years ago
- Views:
Transcription
1
2
3
4
5
6
7
8
9
10
11
12
13 FANCD
14
15
16 PIG-A PIG-A
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55 é
56 íá ñ
57 ü
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74 de novo
75 JAK2
76
77 AML1-EVI1NUP98-HOXD13 DEK-NUP214 FLT3 FMS RAS AML1 RUNX1 p53 RAS
78 p15 INK4b TET2 RPS14TET2 RPS14
79
80
81 ë
82
83
84
85
86
87
88
89
90
91
92
93
94
95 World Health Organization Classification of Tumors Pathology and genetics Tumor of Haematopoietic and lymphoid tissues WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues WHO histological classification of myelodysplastic syndromes in World Health Organization Classification of Tumours Pathology and Genetics of Tumour of Haematopoietic and Lymphoid Tissues Myelodysplastic syndromes/neoplasms overviewwho Classification of Tumours of Haematopoietic and Lymphoid Tissues http //www jslh com/mds pdf
96
97
98 SHCT monograph vol 18
99 Clinical Practice Guidelines in Oncology Myelodysplastic syndromes V 2
100
101
102
103
104
105
106
107 PIG-A
108 PIG-A
109
110
111
112
113
114 ü PIG-A
115 phosphatidylinositolglycan-classa(pig-a) PIG-A
116 PIG-A Pig-a PIG-A PIG-A
117 PIG-A WT1
118 early growth response factor 1 EGR-1TAX-responsive enhancer element binding protein TAXREB107 human A1 hhr23b Mcl-1 RhoA HMGA2 EGR-1HMGA2RhoA
119
120
121 PIG-A
122
123
124
125 PIG-A PIG-A PIG-A PIG-A PIG-A
126
127
128
129
130
131
132
133 é é
134
135
136
137
138
139
140
141 é é é
142 é ö
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158 Treponema pallidum RHD RHCE
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175 ü ö
176
177
178
179
180 ä
181
182
183
184
185
186
187 JAK2 MPL JAK2 AK2JAK2 MPL TET2 TET2 TET2 C-CBL C-CBL ASXL1 ASXL1 ASXL1 ASXL1 EZH2 EZH2
188 EZH2 BCR-ABL JAK2 MPL JAK2 MPL JAK2 MPL
189
190
191
192
193
194
195 JAK2 JAK2
196 JAK2 JAK2 JAK2 JAK2 JAK2 JAK2 TET2JAK2 JAK2 JAK2JAK2 JAK2 JAK2
197 JAK2
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
221 é
222
223
224
225
226
227
228
229
230
231
232
233
234
235 DKC
236 DKC TERC TERT NOP NHP TINF
237
238
239
240
241
242
243
244
245 RPS RPS RPL RPLRPL a
246
247
248 RPS
249
250
251
252
253 é
254
255
256
257
258
259
260
261
262
263
264
265
266
267
268
269 ALAS2 ALAS2 ALAS2
270 ALAS2 ALAS2 SLC25 A38 PUS1 SLC25 A38 PUS1 ABCB7 GLRX5 SLC19A2 SLC19A2 SLC19A2
271 GLRX5 GLRX5 ABCB7PUS1
272 Glutaredoxin5 ABCB7 SLC25A38SLC25A38 ALAS2 SCL19A2 Pseudouridyate synthase 1 gene PUS1
273
274 PUS1
275
医師国家資格試験出題基準(平成17年版)
ü é é ö ! éè é ö ö é ö ö ö ö ! é ! ! !! !! !! ! ! ! ! ! ! ! !! !! !! " !! !!!!!!! !!!!! ! "! !!!!!
More information’¸’_Ł\”ƒ1-4fiñŒÊ
20 23 2011 1 23 24 10 2010 26 11 20 27 12 29 13 22 35 14 2010 36 15 44 23 3 11 23 27 1 11 46 14 188 14 2 16 22 97 3 2 7 3 30 80 19 22 10 1 37 796 4 3 20 30 30 23 3 30 19 4 1 4 8 1 2 4 5 2010 73 22 7 19
More information扉*-p02_OCF4.1
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 ü 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70
More informationuntitled
700 1 2 2 3 4 5 PDF 6 7 8 9 300 400m 1:2.5 1:1.8 75 3.2 10 11 12 1) 1998 Vol1 2) 1987-1992 3) 2001-2002 1-24 4) 1996 17 6-7 5) 2000 31 587-590 6) 2002 22 13 7) 2005 2005 20 46 1 2 3 4 5 6 7 8 9 10 11
More informationISBN4-902715-40-6 i ii iii iv 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 Régime de la Terreur 35 é è 36 37 38 39 40 41 42 43 44 45 46 ü 47 48 49 50
More informationJapan Atherosclerosis Society (JAS) Guidelines for Diagnosis and Treatment of Atherosclerotic Cardiovascular Diseases Contents Chapter 1 Chapter 5 Chapter 2 Chapter 6 Chapter 3 Chapter 7 Chapter 4 Chapter
More information14 13 12 11 10 9 8 7 6 5 4 3 2 1 B1 B2 N
14 13 12 11 10 9 8 7 6 5 4 3 2 1 B1 B2 N L B1 K M K 1F 2F 2 j 5 L 3F 4F É 5F 6F 7F 8F & 9F 10F k & 11F 14F 12F 14F 10 13F 12F 1 2 3 11 12 13 15 14 16 4 5 28 17 7 12 6 19 18 27 8 11 10 9 1 2 3 4 5 6 7 8
More informationB 温泉用語集v2 ABC順090617.xls
é é é üü é ßä ö ß ä é é é ß ö é é ü üö ä é é é é é ä é ä ä éé ä ä ä ä é é éé é Ü é ü é à ä ä ü ö ß ä é â é éé é ß ä ä éé é ö é é ä é é é éé éè éé ä é ü ßß ö œ ß üß à éé é éé é éé é ü ö é ää ä ßßä éé ä
More information13 1 17 1942 1980 7 1 1 2
É 22(1889) 2 5(1916) 3 478 478 518 478 4 CD-ROM 1 75 171 301 347 CD-ROM É 1 13 1 17 1942 1980 7 1 1 2 CD-ROM 1990 22 2 23 5 16 3 22 4 1 110 29 3 193 193 32 7 195 32 8 193 195 32 5 19 11 32 13 21 44 10
More informationuntitled
š š ( œ ) 1,000 23. 3.16 105,041,779 81,238,942 23,802,837 60,287,753 23,802,084 7,692,084 6,310,000 9,800,000 753 753 4,195,443 2,864,813 166,352 1,164,278 56,092,310 1,182,200 105,650 105,650 4,460 50,000,000
More informationŸ š ( š ) 300,000,000 14. 3.22 116,500,963 40,185,547 76,315,416 81,749,456 76,275,801 965,801 63,510,000 11,800,000 39,615 39,615 3,227,059 3,227,059
š ( š ) Ÿœ f 240,000 240,000 130,000 240,000 100,000 240,000 110,000 500,000 240,000 3 240,000 500,000 240,000 240,000 500,000 240,000 500,000 100,000 200,000 200,000 90,000 4,106,000 500,000 14. 4. 1
More informationuntitled
š ( ) œ I 100,000 100,000 100,000 100,000 100,000 100,000 I f 100,000 100,000 100,000 100,000 100,000 100,000 2,000,000 110,000 I 70,000 800,210 4,642,500 (1) 2,366,860 22.11.16 24. 3.15 0 0 24. 5.28 23,351,338
More information第79回_プログラム.indd
Regulation of ghrelin signaling by a leptin-induced gene, negative regulatory element-binding protein, in the hypothalamic neurons. Phase I clinical trial using peptide vaccine for human vascular endothelial
More information1945 47 10 11 12 13 14 792 2003272 273 53 35 54 54915 1999 101994 1999 125715 1999 11451 200322 123 12 45 2 2003 10 11 21 23 13 2 2003 14 15 2003 22 2
2003 20 23 2003 2003 10 2003 14 2003 12 2003 82 3 2003 23 24 198879 2003 9 2003 2004 1152 103 1945 47 10 11 12 13 14 792 2003272 273 53 35 54 54915 1999 101994 1999 125715 1999 11451 200322 123 12 45 2
More informationTABLE of CONTENTS 11 51 65 187 1 2 3 4 5 6 é é 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59
More information1
1 1. 2 1-1. 2 3 1-2.2 4 2. 5 6 7 2-1 2-2 2-3 2-4 2-5 2-1 2-2 2-3 2-4 2-5 PDF PDF 8 P10 9 2-1. 10 2-1. 11 2-1. ( ( 12 2-1. 24 13 2-1. 3 3 14 2-1. 15 2-2. 16 17 2-2. 3 18 2-2. 19 2712 3 1000 20 2841 21 ...
More informationMicrosoft Word - 修正版2 第一部提出.doc
1 myelodysplastic syndromes, MDS MDS MDS MDS anemia of chronic disordersacd aplastic anemia, AA 8 MDS 2005 Mufti idiopathic cytopenias of uncertain significance, ICUS MDS 2006 MDS A ACD MDS MDS B MDS International
More informationCharacterSets.book Japanese
FRAMEMAKER 9 ADOBE i................................................. 2 1 2 1 2 3 4 ú þ ý! " # $ % & ( ) * +, -. / 0 1 2 3 4 5 5 6 7 8 9 : ; < = >? @ A B C D E F G H I J K L M N O P Q R S T U 6 V W X
More informationš ( š ) Ÿ 1,681,268 100,000 16,519,700 (826) 1,661,677 17. 3.31 55,613,224 865,273 54,747,951 55,613,224 2,568,266 2,568,266 52,179,685 52,179,685 33,
Ÿ š ( š ) 400,000 60,000 60,000 1,000,000 100,000 120,000 60,000 120,000 60,000 120,000 120,000 120,000 120,000 120,000 120,000 1,200,000 240,000 60,000 60,000 120,000 60,000 120,000 60,000 600,000 120,000
More informationO157 6/23 7/4 6 25 1000 117,050 6 14:00~15:30 1 2 22 22 14:30~15:30 8 12 1 5 20 6 20 10 11 30 9 10 6 1 30 6 6 0 30 6 19 0 3 27 6 20 0 50 1 2 6 4 61 1 6 5 1 2 1 2 6 19 6 4 15 6 1 6 30 6 24 30 59
More informationみさき_1
2 3 4 5 6 7 1F 2F 8 9 10 11 17 18 19 20 21 22 23 24 31 25 26 27 28 29 30 8 1 2 3 4 5 6 7 6 8 7 16 7 8 9 10 11 12 14 15 13 17 23 Vol.41 8 6 20 11 7 15 7 23 7 7 7 16 23 23 8 13 18:00 22:00 722
More informationVol..3 2010 2 10 2
1 Vol..3 2010 2 10 2 Vol..3 2010 2 10 3 Vol..3 2010 2 10 4 Vol..3 2010 2 10 5 Vol..3 2010 2 10 6 Vol..3 2010 2 10 7 Vol..3 2010 2 10 8 Vol..3 2010 2 10 9 Vol..3 2010 2 10 10 Vol..3 2010 2 10 11 Vol..3
More informationH21_report
vol.4 1 2 6 10 14 18 20 22 24 25 1 2 2172 73 3 21925 926 21125 126 4 5 6 21629 630 7 21107 108 21127 128 8 9 10 21616 617 11 211026 1027 211213 1214 12 13 14 21713 714 15 2194 95 211031 111 16 17 18 19
More information2009-9-2.indd
Q No.1441 Q No.1442 Vol.33 NO.9 (2009) 30 (614) Q No.1443 Vol.33 NO.9 (2009) 31 (615) Q No.1444 Vol.33 NO.9 (2009) 32 (616) Vol.33 NO.9 (2009) 33 (617) Vol.33 NO.9 (2009) 34 (618) Q No.1445 Vol.33 NO.9
More informationuntitled
Vol.27 1 Vol.27 2 Vol.27 3 Vol.27 4 Vol.27 5 Vol.27 6 Vol.27 7 Vol.27 8 Vol.27 9 Vol.27 10 11 Vol.27 Vol.27 12 Vol.27 13 Vol.27 14 Vol.27 15 Vol.27 16 Vol.27 17 Vol.27 2007 10 29 18 http://www.nira.or.jp/index.html
More information